Crossmark

Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw

Crossref DOI link: https://doi.org/10.1007/s10006-018-0688-8

Published Online: 2018-03-05

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mathai, Paul C.

Andrade, Neelam N.

Aggarwal, Neha

Nerurkar, Shibani

Kapoor, Prathmesh
License Information

Text and Data Mining valid from 2018-03-05
More Information

Article History

Received: 27 December 2017

Accepted: 23 February 2018

First Online: 5 March 2018

Compliance with ethical standards

: An informed consent was obtained from the patient. This article does not contain any studies with human participants or animals performed by any of the authors, and hence ethics approval was not required.

: The authors declare that they have no conflict of interest.